select a format

Single User License
USD 1500 INR 96135
Site License
USD 3000 INR 192270
Corporate User License
USD 4500 INR 288405

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Yungjin Pharm. Co., Ltd.-Product Pipeline Review-2015

Yungjin Pharm. Co., Ltd.-Product Pipeline Review-2015


  • Products Id :- GMDHC07410CDB
  • |
  • Pages: 42
  • |
  • August 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Yungjin Pharm. Co., Ltd.-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'Yungjin Pharm. Co., Ltd.-Product Pipeline Review-2015', provides an overview of the Yungjin Pharm. Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Yungjin Pharm. Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Yungjin Pharm. Co., Ltd. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Yungjin Pharm. Co., Ltd.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Yungjin Pharm. Co., Ltd.'s pipeline products

Reasons To Buy

Evaluate Yungjin Pharm. Co., Ltd.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Yungjin Pharm. Co., Ltd. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Yungjin Pharm. Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Yungjin Pharm. Co., Ltd. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Yungjin Pharm. Co., Ltd.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Yungjin Pharm. Co., Ltd. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Yungjin Pharm. Co., Ltd. Snapshot 6

Yungjin Pharm. Co., Ltd. Overview 6

Key Information 6

Key Facts 6

Yungjin Pharm. Co., Ltd.-Research and Development Overview 7

Key Therapeutic Areas 7

Yungjin Pharm. Co., Ltd.-Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products-Monotherapy 11

Pipeline Products-Combination Treatment Modalities 12

Pipeline Products-Partnered Products 13

Partnered Products/Combination Treatment Modalities 14

Yungjin Pharm. Co., Ltd.-Pipeline Products Glance 15

Yungjin Pharm. Co., Ltd.-Late Stage Pipeline Products 15

Pre-Registration Products/Combination Treatment Modalities 15

Phase III Products/Combination Treatment Modalities 16

Yungjin Pharm. Co., Ltd.-Clinical Stage Pipeline Products 17

Phase II Products/Combination Treatment Modalities 17

Phase I Products/Combination Treatment Modalities 18

Yungjin Pharm. Co., Ltd.-Early Stage Pipeline Products 19

Preclinical Products/Combination Treatment Modalities 19

Discovery Products/Combination Treatment Modalities 20

Yungjin Pharm. Co., Ltd.-Drug Profiles 21

KTG-001 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

(acetaminophen + tramadol hydrochloride) SR 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

YPL-001 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

YBH-1603 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

YNP-1707 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

YOB-1604 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

ceftaroline fosamil 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

YAR-1502 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

YHT-1808 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

YLS-1501 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

YPU-1705 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

YRA-1909 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

YGD-1710 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

YPE-1706 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

Yungjin Pharm. Co., Ltd.-Pipeline Analysis 35

Yungjin Pharm. Co., Ltd.-Pipeline Products by Target 35

Yungjin Pharm. Co., Ltd.-Pipeline Products by Route of Administration 36

Yungjin Pharm. Co., Ltd.-Pipeline Products by Molecule Type 37

Yungjin Pharm. Co., Ltd.-Pipeline Products by Mechanism of Action 38

Yungjin Pharm. Co., Ltd.-Dormant Projects 39

Yungjin Pharm. Co., Ltd.-Locations And Subsidiaries 40

Head Office 40

Appendix 41

Methodology 41

Coverage 41

Secondary Research 41

Primary Research 41

Expert Panel Validation 41

Contact Us 41

Disclaimer 42

List of Tables

Yungjin Pharm. Co., Ltd., Key Information 6

Yungjin Pharm. Co., Ltd., Key Facts 6

Yungjin Pharm. Co., Ltd.-Pipeline by Indication, 2015 9

Yungjin Pharm. Co., Ltd.-Pipeline by Stage of Development, 2015 10

Yungjin Pharm. Co., Ltd.-Monotherapy Products in Pipeline, 2015 11

Yungjin Pharm. Co., Ltd.-Combination Treatment Modalities in Pipeline, 2015 12

Yungjin Pharm. Co., Ltd.-Partnered Products in Pipeline, 2015 13

Yungjin Pharm. Co., Ltd.-Partnered Products/ Combination Treatment Modalities, 2015 14

Yungjin Pharm. Co., Ltd.-Pre-Registration, 2015 15

Yungjin Pharm. Co., Ltd.-Phase III, 2015 16

Yungjin Pharm. Co., Ltd.-Phase II, 2015 17

Yungjin Pharm. Co., Ltd.-Phase I, 2015 18

Yungjin Pharm. Co., Ltd.-Preclinical, 2015 19

Yungjin Pharm. Co., Ltd.-Discovery, 2015 20

Yungjin Pharm. Co., Ltd.-Pipeline by Target, 2015 35

Yungjin Pharm. Co., Ltd.-Pipeline by Route of Administration, 2015 36

Yungjin Pharm. Co., Ltd.-Pipeline by Molecule Type, 2015 37

Yungjin Pharm. Co., Ltd.-Pipeline Products by Mechanism of Action, 2015 38

Yungjin Pharm. Co., Ltd.-Dormant Developmental Projects,2015 39

List of Figures

Yungjin Pharm. Co., Ltd.-Pipeline by Top 10 Indication, 2015 8

Yungjin Pharm. Co., Ltd.-Pipeline by Stage of Development, 2015 10

Yungjin Pharm. Co., Ltd.-Monotherapy Products in Pipeline, 2015 11

Yungjin Pharm. Co., Ltd.-Pipeline by Top 10 Target, 2015 35

Yungjin Pharm. Co., Ltd.-Pipeline by Top 10 Route of Administration, 2015 36

Yungjin Pharm. Co., Ltd.-Pipeline by Top 10 Molecule Type, 2015 37

Yungjin Pharm. Co., Ltd.-Pipeline Products by Top 10 Mechanism of Action, 2015 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Yungjin Pharm. Co., Ltd.; Yungjin Pharm. Co., Ltd. - Key Therapeutics; Yungjin Pharm. Co., Ltd. - Pipeline Overview and Promising Molecules; Yungjin Pharm. Co., Ltd. - News; Yungjin Pharm. Co., Ltd. - Latest Updates; Yungjin Pharm. Co., Ltd. - Pipeline; Yungjin Pharm. Co., Ltd. - Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com